NJ hospitals seeing progress in fight against baby bloodstream infections

Since 2011, Neonatal Intensive Care Units (NICU) in nine states, including New Jersey, have participated in a national CLABSI reduction project. Central-line Associated Bloodstream Infections, or CLABSI, occur when bacteria or viruses enter an individual through a central venous catheter, a much-needed tool in order to deliver medicine, fluids or blood products to infants who can’t support themselves just yet. In newborns, CLABSI is considered a significant contributor to morbidity and mortality for infants. Kevin Slavin, M.D., chief of quality and safety, Joseph M. Sanzari Children’s Hospital at Hackensack University Medical Center, was featured in this report saying hospitals have revamped their techniques around the insertion of maintenance of these lines.